New graphene-containing pharmaceutical formulations for infrared lamps-based phototherapy of skin cancer : In vitro validation and ex-vivo human skin permeation
Copyright © 2024. Published by Elsevier Inc..
Basal cell carcinoma (BCC) is the most common form of human cancer, and treatment usually involves surgery, with alternative strategies being needed. We propose the use of carbopol hydrogels (HG) for topical administration of nanographene oxide (GOn) and partially-reduced nanographene oxide (p-rGOn) for photothermal therapy (PTT) of BCC. GOn and p-rGOn incorporated into the HG present lateral sizes ∼200 nm, being stable for 8 months. After 20 min irradiation with an infrared (IR) photothermal therapy lamp (15.70 mW cm-2), GOn-HG increased temperature to 44.7 °C, while p-rGOn-HG reached 47.0 °C. Human skin fibroblasts (HFF-1) cultured with both hydrogels (250 μg mL-1) maintained their morphology and viability. After 20 min IR irradiation, p-rGOn HG (250 μg mL-1) completely eradicated skin cancer cells (A-431). Ex vivo human skin permeability tests showed that the materials can successfully achieve therapeutic concentrations (250 μg mL-1) inside the skin, in 2.0 h for GO HG or 0.5 h for p-rGOn HG.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
Nanomedicine : nanotechnology, biology, and medicine - 57(2024) vom: 15. Apr., Seite 102734 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Silva, Filipa A L S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
7782-42-5 |
|---|
| Anmerkungen: |
Date Completed 02.04.2024 Date Revised 02.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.nano.2024.102734 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368090140 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368090140 | ||
| 003 | DE-627 | ||
| 005 | 20240403000145.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240207s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.nano.2024.102734 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1361.xml |
| 035 | |a (DE-627)NLM368090140 | ||
| 035 | |a (NLM)38295912 | ||
| 035 | |a (PII)S1549-9634(24)00003-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Silva, Filipa A L S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a New graphene-containing pharmaceutical formulations for infrared lamps-based phototherapy of skin cancer |b In vitro validation and ex-vivo human skin permeation |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.04.2024 | ||
| 500 | |a Date Revised 02.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024. Published by Elsevier Inc. | ||
| 520 | |a Basal cell carcinoma (BCC) is the most common form of human cancer, and treatment usually involves surgery, with alternative strategies being needed. We propose the use of carbopol hydrogels (HG) for topical administration of nanographene oxide (GOn) and partially-reduced nanographene oxide (p-rGOn) for photothermal therapy (PTT) of BCC. GOn and p-rGOn incorporated into the HG present lateral sizes ∼200 nm, being stable for 8 months. After 20 min irradiation with an infrared (IR) photothermal therapy lamp (15.70 mW cm-2), GOn-HG increased temperature to 44.7 °C, while p-rGOn-HG reached 47.0 °C. Human skin fibroblasts (HFF-1) cultured with both hydrogels (250 μg mL-1) maintained their morphology and viability. After 20 min IR irradiation, p-rGOn HG (250 μg mL-1) completely eradicated skin cancer cells (A-431). Ex vivo human skin permeability tests showed that the materials can successfully achieve therapeutic concentrations (250 μg mL-1) inside the skin, in 2.0 h for GO HG or 0.5 h for p-rGOn HG | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Biocompatibility | |
| 650 | 4 | |a Carbopol 974P NF | |
| 650 | 4 | |a Graphene-based materials | |
| 650 | 4 | |a Photothermal therapy | |
| 650 | 4 | |a Skin permeability | |
| 650 | 7 | |a Graphite |2 NLM | |
| 650 | 7 | |a 7782-42-5 |2 NLM | |
| 650 | 7 | |a Hydrogels |2 NLM | |
| 650 | 7 | |a Oxides |2 NLM | |
| 700 | 1 | |a Pinto, Soraia |e verfasserin |4 aut | |
| 700 | 1 | |a Santos, Susana G |e verfasserin |4 aut | |
| 700 | 1 | |a Magalhães, Fernão D |e verfasserin |4 aut | |
| 700 | 1 | |a Sarmento, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Pinto, Artur M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nanomedicine : nanotechnology, biology, and medicine |d 2005 |g 57(2024) vom: 15. Apr., Seite 102734 |w (DE-627)NLM16062021X |x 1549-9642 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2024 |g day:15 |g month:04 |g pages:102734 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nano.2024.102734 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2024 |b 15 |c 04 |h 102734 | ||